Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 06, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations

aTyr Pharma Announces Appointment of Jayant Aphale, PhD, as Vice President of Technical Operations
July 22, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Completes Enrollment in Global Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis

aTyr Pharma Completes Enrollment in Global Pivotal Phase 3 EFZO-FIT™ Study of Efzofitimod in Pulmonary Sarcoidosis
June 03, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”

aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
May 15, 2024 07:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference

aTyr Pharma to Present Poster Describing Efzofitimod’s Mechanism of Action at the American Thoracic Society 2024 International Conference
May 14, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis

aTyr Pharma Announces Second Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
May 06, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present at Upcoming Investor Conferences

aTyr Pharma to present at upcoming investor conferences.
May 02, 2024 16:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces First Quarter 2024 Results and Provides Corporate Update

aTyr Pharma announces first quarter 2024 results and provides corporate update
March 14, 2024 16:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update

aTyr Pharma Announces Fourth Quarter and Full Year 2023 Results and Provides Corporate Update
February 21, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants

Tyr Pharma Announces Expanded Access Program (EAP) for EFZO-FIT™ Clinical Trial Participants
January 29, 2024 08:00 ET | Source: aTyr Pharma, Inc.

aTyr Pharma to Present Posters Highlighting Importance of Neuropilin-2 in Immune Regulation at Keystone Symposia on Myeloid Cell Diversity

aTyr Pharma to present posters on the importance of Neuropilin-2 in immune regulation at the Keystone Symposia on Myeloid Cell Diversity.